Medical Supplies Stocks on Investors' Radar -- Endologix, Microbot Medical, ConforMIS, and Insulet

Wednesday, June 21, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 21, 2017 /PRNewswire/ --

If you want a stock review on ELGX, MBOT, CFMS, or PODD then come over to

http://dailystocktracker.com/register/ and sign up for your free customized reports today. On Tuesday, June 20, 2017, US markets saw broad based losses with eight out of nine sectors finishing the trading sessions in
red. Major US indices were also bearish at the close of yesterday's session. The NASDAQ Composite ended the day at 6,188.03, down 0.82%; the Dow Jones Industrial Average edged 0.29% lower, to finish at 21,467.14; and the S&P 500 closed at 2,437.03, down 0.67%. This Wednesday morning, DailyStockTracker.com looks at the performance of these four Medical Instruments & Supplies stocks: Endologix Inc. (NASDAQ: ELGX), Microbot Medical Inc. (NASDAQ: MBOT), ConforMIS Inc. (NASDAQ: CFMS), and Insulet Corp. (NASDAQ: PODD). This morning's free research reports on the aforesaid equities can be accessed upon registration on DailyStockTracker.com at:

http://dailystocktracker.com/register/

Endologix 

Irvine, California headquartered Endologix Inc.'s stock finished Tuesday's session 4.35% lower at $4.62 with a total trading volume of 505,467 shares. The Company's shares have advanced 4.05% in the past month. The stock is trading below its 50-day moving average by 22.99%. Furthermore, shares of Endologix, which develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the US and internationally, have a Relative Strength Index (RSI) of 37.83. Visit us today and download your complete report on ELGX for free at:

http://dailystocktracker.com/registration/?symbol=ELGX

Microbot Medical 

Shares in Yokneam, Israel-based Microbot Medical Inc. ended at $1.43, down 12.80% from the last trading session. The stock recorded a trading volume of 1.55 million shares, which was above its three months average volume of 562,100 shares. The Company's shares are trading 63.70% below their 50-day moving average. Moreover, shares of Microbot Medical, which engages in the research, design, development, and commercialization of micro-robotics medical technologies, have an RSI of 30.49. The complimentary research report on MBOT can be accessed at:

http://dailystocktracker.com/registration/?symbol=MBOT

ConforMIS 

Bedford, Massachusetts headquartered ConforMIS Inc.'s stock ended yesterday's session 9.80% lower at $4.05. A total volume of 543,162 shares was traded, which was above their three months average volume of 265,430 shares. The Company's shares are trading 17.35% below their 50-day moving average. Additionally, shares of ConforMIS, which develops, manufactures, and sells customized joint replacement implants, have an RSI of 40.74. Register for free on DailyStockTracker.com and download the research report on CFMS at:

http://dailystocktracker.com/registration/?symbol=CFMS

Insulet 

On Tuesday, shares in Billerica, Massachusetts headquartered Insulet Corp. recorded a trading volume of 297,852 shares. The stock finished 1.03% lower at $47.94. The Company's shares have advanced 14.14% in the last one month, 12.96% in the previous three months, and 27.23% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 13.04% and 17.01%, respectively. Furthermore, shares of Insulet, which develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the US and internationally, have an RSI of 71.31.

On May 25th, 2017, research firm William Blair resumed its 'Outperform' rating on the Company's stock. Get free access to your research report on PODD at:

http://dailystocktracker.com/registration/?symbol=PODD

--

Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://dailystocktracker.com/disclaimer/

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number:  (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store